Condition : Juvenile Idiopathic Arthritis Intervention : Drug: CP-690,550 Sponsor : Pfizer Recruiting - verified February 2014

Condition : Juvenile Idiopathic Arthritis Intervention : Drug: CP-690,550 Sponsor : Pfizer Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Interventions : Biological: Certolizumab Pegol + Methotrexate (CZP + MTX); Biological: Adalimumab + Methotrexate (ADA + MTX) Sponsors : UCB, Inc.; UCB Pharma SA Active...

Condition : Psoriasis Interventions : Drug: CP-690,550; Drug: CP-690, 550 Sponsor : Pfizer Recruiting - verified November 2013

Condition : Juvenile Idiopathic Arthritis Intervention : Drug: CP-690,550 Sponsors : Pfizer; Pfizer Recruiting - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Biological: Certolizumab Pegol + Methotrexate (CZP + MTX); Biological: Adalimumab + Methotrexate (ADA + MTX) Sponsors : UCB, Inc.; UCB Pharma SA Recrui...

Condition : Psoriasis Interventions : Drug: CP-690,550; Drug: CP-690, 550 Sponsors : Pfizer; Pfizer Recruiting - verified September 2013

Condition : Intraarticular Fracture and Post-traumatic Osteoarthritis Intervention : Sponsor : University of Utah Recruiting - verified February 2014

Condition : Gout Interventions : Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo Sponsor : Ardea Biosciences, Inc. Active, not recruiting - verified February 2014

Condition : Gout Interventions : Drug: Lesinurad; Drug: Lesinurad; Drug: Placebo Sponsor : Ardea Biosciences, Inc. Active, not recruiting - verified November 2013